221 related articles for article (PubMed ID: 36544095)
1. Clinicopathological findings, prognosis, and Epstein-Barr virus infection in rheumatoid arthritis patients with other iatrogenic immunodeficiency-associated T- and NK-cell lymphoproliferative disorders.
Kimura S; Oshiro Y; Iwasaki H; Kadowaki M; Ogata M; Daa T; Sakata T; Kawauchi S; Wang Z; Takamatsu Y; Takeshita M
BMC Cancer; 2022 Dec; 22(1):1342. PubMed ID: 36544095
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological analyses in patients with other iatrogenic immunodeficiency-associated lymphoproliferative diseases and rheumatoid arthritis.
Tokuhira M; Watanabe R; Nemoto T; Sagawa M; Tomikawa T; Tamaru J; Itoyama S; Nagasawa H; Amano K; Kameda H; Takeuchi T; Mori S; Kizaki M
Leuk Lymphoma; 2012 Apr; 53(4):616-23. PubMed ID: 21933041
[TBL] [Abstract][Full Text] [Related]
3. Case Report: Composite Angioimmunoblastic T-Cell Lymphoma and Epstein-Barr Virus-Positive B-Cell Lymphoproliferative Disorder as Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders.
Kakiuchi S; Yakushijin K; Takagi I; Rikitake J; Akiyama H; Matsuba H; Hayashi Y; Kajimoto K; Iwata N
Front Med (Lausanne); 2020; 7():625442. PubMed ID: 33425968
[TBL] [Abstract][Full Text] [Related]
4. Mature T/NK-cell lymphoproliferative disease and Epstein-Barr virus infection are more frequent in patients with rheumatoid arthritis treated with methotrexate.
Kondo S; Tanimoto K; Yamada K; Yoshimoto G; Suematsu E; Fujisaki T; Oshiro Y; Tamura K; Takeshita M; Okamura S
Virchows Arch; 2013 Apr; 462(4):399-407. PubMed ID: 23494713
[TBL] [Abstract][Full Text] [Related]
5. Increased MYC expression without MYC gene translocation in patients with the diffuse large B-cell-lymphoma subtype of iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Kabasawa N; Shiozawa E; Murai S; Homma M; Uesugi Y; Matsui T; Nakata A; Shimada S; Sasaki Y; Baba Y; Watanuki M; Arai N; Fujiwara S; Kawaguchi Y; Tsukamoto H; Uto Y; Yanagisawa K; Hattori N; Sakai H; Harada H; Nakamaki T; Takimoto M; Yamochi-Onizuka T
J Clin Exp Hematop; 2021; 61(3):120-125. PubMed ID: 34511544
[TBL] [Abstract][Full Text] [Related]
6. Methotrexate-related Epstein-Barr virus-associated lymphoproliferative disorder occurring in the gingiva of a patient with rheumatoid arthritis.
Ishida M; Hodohara K; Yoshii M; Okuno H; Horinouchi A; Nakanishi R; Harada A; Iwai M; Yoshida K; Kagotani A; Yoshida T; Okabe H
Int J Clin Exp Pathol; 2013; 6(10):2237-41. PubMed ID: 24133604
[TBL] [Abstract][Full Text] [Related]
7. Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders with a T- or NK-cell phenotype.
Satou A; Tsuzuki T; Nakamura S
J Clin Exp Hematop; 2019; 59(2):56-63. PubMed ID: 31257346
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of rheumatoid arthritis with immunodeficiency-associated lymphoproliferative disorders to regress spontaneously by the withdrawal of methotrexate and their clinical course: A retrospective, multicenter, case-control study.
Kuramoto N; Saito S; Fujii T; Kaneko Y; Saito R; Tanaka M; Takada H; Nakano K; Saito K; Sugimoto N; Sasaki S; Harigai M; Suzuki Y
Mod Rheumatol; 2022 Jan; 32(1):24-31. PubMed ID: 33496194
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, Epstein-Barr virus, and clonality are important predictors of disease progression and regression.
Ichikawa A; Arakawa F; Kiyasu J; Sato K; Miyoshi H; Niino D; Kimura Y; Takeuchi M; Yoshida M; Ishibashi Y; Nakashima S; Sugita Y; Miura O; Ohshima K
Eur J Haematol; 2013 Jul; 91(1):20-8. PubMed ID: 23560463
[TBL] [Abstract][Full Text] [Related]
10. Association of Epstein-Barr virus with regression after withdrawal of immunosuppressive drugs and subsequent progression of iatrogenic immunodeficiency-associated lymphoproliferative disorders in patients with autoimmune diseases.
Fujimoto K; Hatanaka KC; Hatanaka Y; Kasahara I; Yamamoto S; Tsuji T; Nakata M; Takakuwa Y; Haseyama Y; Oyamada Y; Yonezumi M; Suzuki H; Sakai H; Noguchi H; Mori A; Nishihara H; Teshima T; Matsuno Y
Hematol Oncol; 2020 Dec; 38(5):799-807. PubMed ID: 32798315
[TBL] [Abstract][Full Text] [Related]
11. Benign, atypical and malignant lymphoproliferative disorders in rheumatoid arthritis patients.
Kojima M; Motoori T; Nakamura S
Biomed Pharmacother; 2006 Dec; 60(10):663-72. PubMed ID: 17064872
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate-related Epstein-Barr Virus (EBV)-associated lymphoproliferative disorder--so-called "Hodgkin-like lesion"--of the oral cavity in a patient with rheumatoid arthritis.
Kikuchi K; Miyazaki Y; Tanaka A; Shigematu H; Kojima M; Sakashita H; Kusama K
Head Neck Pathol; 2010 Dec; 4(4):305-11. PubMed ID: 20676828
[TBL] [Abstract][Full Text] [Related]
15. [Iatrogenic immunodeficiency-associated Epstein-Barr virus (EBV) -negative natural killer cell lymphoproliferative disorder in a patient undergoing rheumatoid arthritis therapy].
Uchida T; Inoue M; Hua J; Tajima S; Ota Y; Hagihara M
Rinsho Ketsueki; 2017; 58(6):624-629. PubMed ID: 28679993
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological analysis of the age-related differences in patients with Epstein-Barr virus (EBV)-associated extranasal natural killer (NK)/T-cell lymphoma with reference to the relationship with aggressive NK cell leukaemia and chronic active EBV infection-associated lymphoproliferative disorders.
Takahashi E; Ohshima K; Kimura H; Hara K; Suzuki R; Kawa K; Eimoto T; Nakamura S;
Histopathology; 2011 Oct; 59(4):660-71. PubMed ID: 22014047
[TBL] [Abstract][Full Text] [Related]
17. Somatic mutations in
Gao LM; Zhao S; Zhang WY; Wang M; Li HF; Lizaso A; Liu WP
Cancer Biol Ther; 2019; 20(10):1319-1327. PubMed ID: 31311407
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate-associated lymphoproliferative disorders mimicking angioimmunoblastic T-cell lymphoma.
Hatanaka K; Nakamura N; Kojima M; Ando K; Irie S; Bunno M; Nakamine H; Uekusa T
Pathol Res Pract; 2010 Jan; 206(1):9-13. PubMed ID: 19628340
[TBL] [Abstract][Full Text] [Related]
19. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders.
Tokuhira M; Tamaru JI; Kizaki M
J Clin Exp Hematop; 2019; 59(2):72-92. PubMed ID: 31257348
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-related lymphoma in rheumatoid arthritis: implications for long-term usage of immunosuppressive drugs and review of the literature.
He J; Williamson L; Cai K; Wong P; Sturgess A; Taper J; Manolios N
Intern Med J; 2022 Oct; 52(10):1717-1723. PubMed ID: 34028145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
